🔗 Share this article

Treasury head Rachel Reeves has revealed she is preparing "focused measures to address cost of living pressures" in the upcoming Budget.

During an interview with media outlets, she stated that lowering price rises is a shared responsibility of both the government and the Bank of England.

The United Kingdom's price growth is expected to be the highest among the Group of Seven industrialized countries this calendar year and next.

Possible Energy Bill Measures

Reports indicate the administration could intervene to bring down energy bills, such as by slashing the current 5% level of VAT applied on energy.

Another approach is to reduce some of the government charges currently added to bills.

Budgetary Limitations and Expert Expectations

The administration will receive the latest assessment from the official forecaster, the OBR, on Monday, which will reveal how much space there is for these measures.

The consensus from the majority of experts is that the Chancellor will have to announce tax rises or spending cuts in order to fulfill her voluntary debt limits.

Previously on Thursday, estimates indicated there was a twenty-two billion pound shortfall for the chancellor to address, which is at the lower end of expectations.

"There's a joint task between the Bank of England and the administration to bear down further on some of the causes of price increases," the Chancellor told reporters in the US capital, at the yearly gatherings of the IMF and global financial institution.

Revenue Commitments and International Issues

While much of the focus has been on expected tax increases, the chancellor said the most recent data from the fiscal watchdog had not altered her commitment to manifesto promises not to increase tax levels on earnings tax, VAT or social security contributions.

She attributed an "uncertain global environment" with increasing international and commercial concerns for the fiscal tax moves, likely to be directed on those "with the broadest shoulders."

International Trade Disputes

Commenting on worries about the United Kingdom's economic relations with the Asian nation she said: "The UK's security interests always take priority."

Last week's declaration by China to tighten trade restrictions on critical minerals and other resources that are key for advanced tech production led American leader Donald Trump to propose an extra 100% import tax on goods from the Asian country, raising the prospect of an full-scale commercial conflict between the two economic giants.

The American finance chief described the Chinese decision "economic coercion" and "a global supply chain power grab."

Asked about accepting the US offer to participate in its dispute with the Asian nation, Reeves said she was "deeply worried" by China's actions and urged the Chinese government "not to put up barriers and restrict access."

She said the move was "harmful for the international commerce and generates further obstacles."

"I believe there are fields where we must confront China, but there are also valuable opportunities to export to China's economy, including financial services and other sectors of the economy. We've got to get that equilibrium correct."

The Treasury chief also affirmed she was collaborating with international partners "on our own essential resources plan, so that we are reduced dependence."

Health Service Medicine Pricing and Investment

The Chancellor also recognized that the price the NHS pays for medicines could increase as a consequence of ongoing discussions with the US government and its pharmaceutical firms, in exchange for lower tariffs and capital.

Some of the world's largest pharmaceutical manufacturers have said in recent statements that they are either pausing or canceling investments in the UK, with some blaming the modest returns they are getting.

Last month, the government science advisor said the price the health service spends on medicines would must rise to prevent businesses and pharmaceutical investment leaving the United Kingdom.

The Chancellor stated to the BBC: "We have seen due to the cost structure, that drug testing, recent pharmaceuticals have not been provided in the UK in the way that they are in other European countries."

"Our aim is to make sure that individuals getting care from the NHS are can receive the finest essential drugs in the globe. And so we are looking at these issues, and... seeking to attract additional investment into the UK."